USPTO serial 87026844
AVACTA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 30, 2018
- Examiner
- BEVERLY, JOSETTE MICHELLE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 704 applies to Madrid Protocol extensions of protection in the U.S. Section 71 (similar to Section 8) showing continued use was accepted. The U.S. extension remains active. Follow Madrid and USPTO deadlines for the next renewal cycle.
Need help with AVACTA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christina M. Licursi
Christina M. Licursi Wolf Greenfield & Sacks, P.C.600 Atlantic AvenueBoston, MA 02210United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Reagents for use in scientific research; reagents for use in scientific screening; [ genetic identity tests comprised of reagents for non-medical purposes; genetic identity tests for animals comprised of reagents for non-medical purposes; ] reagents for use in scientific, medical, [ and/or veterinary research; ] affinity reagents, including antibodies, [ and diagnostic kits ] consisting primarily of antibodies and reagents, all for use in scientific, medical, [ and/or veterinary ] research; chemical preparations containing antigens for use in scientific, medical, [ and/or veterinary ] research [; chemical preparations containing antigens for scientific diagnostic use; diagnostic and/or pharmaceutical preparations containing antibodies for scientific diagnostic use; substrates impregnated with or carrying antibodies for scientific diagnostic use; diagnostic kits consisting primarily of diagnostic reagents, affinity reagents, antibodies, antigens, wound dressings and/or antiseptic wipes for scientific diagnostic use; antibodies for scientific diagnostic use; diagnostic preparations containing antibodies for scientific diagnostic use; substrates impregnated with or carrying antibodies for scientific diagnostic use; diagnostic kits consisting primarily of diagnostic reagents, affinity reagents, antibodies, antigens, wound dressings and/or antiseptic wipes for scientific diagnostic use ] | ACTIVE | — |
| 005 | [ Reagents for use in veterinary and medical diagnostic tests; reagents for use in medical and veterinary screening; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood; diagnostic preparations for use in relation to food intolerance testing; affinity reagents, including antibodies, and diagnostic kits consisting primarily of medical antibodies and reagents for medical and veterinary use for use in medical and veterinary screening for the detection of diseases, allergies, infections, disorders, and for immunity testing; antigens for medical diagnostic use and veterinary diagnostic use; pharmaceutical preparations containing antigens for use in medical and veterinary treatment; substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use; antibodies for medical diagnostic use and veterinary diagnostic use; diagnostic and/or pharmaceutical preparations containing antibodies for medical diagnostic use and veterinary diagnostic use; substrates impregnated with or carrying antibodies for medical diagnostic use and veterinary diagnostic use; wound dressings; medical plasters; antiseptic wipes; diagnostic kits consisting primarily of diagnostic reagents, affinity reagents, antibodies, antigens, wound dressings and/or antiseptic wipes for medical diagnostic use and veterinary diagnostic use; genetic identity tests comprised of reagents for medical purposes; genetic identity tests for animals comprised of reagents for medical purposes; in-vitro diagnostic tests for predicting gender; in-vitro ovulation prediction test kits for home use; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergies ] | SECTION 8 - CANCELLED | — |
| 010 | [ Medical laboratory apparatus for medical diagnosis for serological immunity and genetics, allergies, ectoparasites, fungal infections, bacterial or malassezia infections, ear infections, atopic dermatitis, anal gland disorders, asthma, equine recurrent airway obstruction, or insect bites hypersensitivity; diagnostic apparatus for medical and veterinary use, namely, serological immune-assays and genetic testing apparatus; genetic testing kits comprised of reagents and testing apparatus for medical purposes; genetic testing kits comprised of reagents and testing apparatus for medical purposes for animals; medical apparatus for identifying genetic status for use in the diagnosis of genetic diseases; medical apparatus for identifying genetic disease for medical use; apparatus for use in taking and/or collecting biological samples, particularly blood samples; apparatus for use in taking and/or collecting samples from animals, particularly blood samples; blood and tissue testing apparatus for use in assays of biological samples, particularly blood for the detection of proteins; blood and tissue testing apparatus for use in assays of blood and tissue samples from animals; lancets; blood collection devices, namely, glass slides, cups, bags, syringes, tubes, vials; absorbent devices for collecting blood, namely, sponges, polymer materials, gels and cloths; containers adapted for the disposal of medical instruments, syringes and other contaminated medical waste and containers adapted to contain sterile sponges, polymer materials, gels and cloths for collecting blood; medical apparatus for use in assays of veterinary samples, particularly blood; biological sample testing kits comprised of blood collection devices, namely, glass slides, cups, bags, syringes, tubes, vials, absorbent devices for collecting blood, namely, sponges, polymer materials, gels and cloths, and/or containers adapted for the disposal of medical instruments, syringes and other contaminated medical waste and containers adapted to contain sterile sponges, polymer materials, gels and cloths for collecting blood; blood collection kits comprised of blood collection bags, holders for medical sample tubes and vials, and medical sample tubes and vials; blood collection kits comprised of blood collection bags, holders for medical sample tubes and vials, and medical sample tubes and vials for use in relation to animals; test apparatus for carrying out diagnostic tests on human or animal blood and tissue for purposes relating to the health or wellbeing of humans and/or animals; apparatus for performing in vitro diagnostic tests, namely, lateral flow devices, dipstick tests, biosensors, immunoassay apparatus; analyzers for in-vitro medical diagnostic tests; blood taking and collection kits comprising lancets and blood collecting tubes; veterinary and medical sample testing kits comprised of blood collection devices, namely, glass slides, cups, bags, syringes, tubes, vials, absorbent devices for collecting blood, namely, sponges, polymer materials, gels and cloths, and/or containers adapted for the disposal of medical instruments, syringes and other contaminated medical waste and containers adapted to contain sterile sponges, polymer materials, gels and cloths for collecting blood, blood testing apparatus and materials, namely, blood collecting tubes and sampling sold in kit form for use in taking and/or testing veterinary and medical samples, particularly blood ] | SECTION 8 - CANCELLED | — |
| 042 | Scientific services namely scientific laboratory services; scientific research and development services; laboratory research services and laboratory testing services [ in the field of medical diagnostics; ] laboratory research services and laboratory testing services all relating to the examination, analysis or assaying of biological samples [; laboratory research services and laboratory testing services, all relating to the examination, analysis or assaying of samples from animals; blood analysis; providing medical and scientific research information in the field of medical diagnostics, blood analysis and genetics including by computer networks and/or the Internet; preparation of reports relating to laboratory tests in the fields of medical diagnostics, blood analysis and genetics ] | ACTIVE | — |
| 044 | [ Antibody medical screening services; food intolerance medical testing; allergy medical testing; medical infection testing; medical services for detecting or measuring factors indicative of health conditions or disorders; medical services for detecting or measuring selected antibodies in biological samples; antibody screening services; medical testing for diseases; providing medical information relating to the aforesaid services including by computer networks and/or the Internet; providing medical information, consultancy and advisory services relating to any of the aforesaid services; genetic testing services for medical diagnostic purposes; medical consultancy and advisory services in the fields of medical diagnostics, blood analysis and genetics ] | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Avacta Limited
- Other trademarks owned by Avacta Limited
- Other trademarks owned by Avacta Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named AVACTA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 19, 2025 | NAS8 | NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED | — |
| Aug 19, 2025 | 8.PR | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED | — |
| Aug 11, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 29, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Apr 29, 2025 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Apr 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 29, 2025 | ES8R | TEAS SECTION 8 RECEIVED | — |
| Oct 30, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 15, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 15, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 22, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 23, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 20, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 5, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 4, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 3, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 3, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2017 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| May 2, 2017 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 18, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 5, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 1, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 6, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 18, 2016 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Jun 8, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 26, 2016 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| May 10, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 9, 2016 | NWAP | NEW APPLICATION ENTERED | — |